|Articles|February 24, 2020
MALDI-DIT Analysis of Modification Site of Chemically Modified Antibody
Author(s)Shimadzu
This application note showcases the high MSn analysis capability of an ultra-compact MALDI digital ion trap (DIT) mass spectrometer, and its ability to obtain information from modified peptides.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
AdvanCell Targets GI Cancer With Peptide-Driven Lead-212 Radiotherapy
3
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
4
Genentech Expands RNAi Pipeline Through Global Licensing Deal
5